Results 151 to 160 of about 16,834 (166)

Bilateral Mastectomy and Breast Cancer Mortality.

JAMA Oncol
Giannakeas V, Lim DW, Narod SA.
europepmc   +1 more source

Serum Levels of Copper and Zinc and Survival in Breast Cancer Patients. [PDF]

Nutrients
Szwiec M, Marciniak W, Derkacz R, Huzarski T, Gronwald J, Cybulski C, Dębniak T, Jakubowska A, Lener MR, Falco M, Kładny J, Baszuk P, Kotsopoulos J, Narod SA, Lubiński J.   +14 more
europepmc   +1 more source

Risk-benefits assessment of tamoxifen or raloxifene as chemoprevention for risk reduction of breast cancer among BRCA1 and BRCA2 carriers: a meta-analysis. [PDF]

Sci Rep
Alwashmi ASS, Khan NU, Chen T.
europepmc   +1 more source

Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers. [PDF]

Antioxidants (Basel)
Matuszczak M, Kiljańczyk A, Marciniak W, Derkacz R, Stempa K, Baszuk P, Bryśkiewicz M, Sun P, Cheriyan A, Cybulski C, Dębniak T, Gronwald J, Huzarski T, Lener MR, Jakubowska A, Szwiec M, Stawicka-Niełacna M, Godlewski D, Prusaczyk A, Jasiewicz A, Kluz T, Tomiczek-Szwiec J, Kilar-Kobierzycka E, Siołek M, Wiśniowski R, Posmyk R, Jarkiewicz-Tretyn J, Scott RJ, Narod SA, Lubiński J.   +29 more
europepmc   +1 more source

Impact of Pre-Diagnostic Risk Factors on Short- and Long-Term Ovarian Cancer Survival Trajectories: A Longitudinal Observational Study. [PDF]

Cancers (Basel)
Kim SJ, Tworoger SS, Rosen BP, McLaughlin JR, Risch HA, Narod SA, Kotsopoulos J.   +6 more
europepmc   +1 more source

MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations.

JAMA Oncol
Lubinski J, Kotsopoulos J, Moller P, Pal T, Eisen A, Peck L, Karlan BY, Aeilts A, Eng C, Bordeleau L, Foulkes WD, Tung N, Couch FJ, Fruscio R, Ramon Y Cajal T, Singer CF, Neuhausen SL, Zakalik D, Cybulski C, Gronwald J, Huzarski T, Stempa K, Dungan J, Cullinane C, Olopade OI, Metcalfe K, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group.   +28 more
europepmc   +1 more source

Blood molybdenum level as a marker of cancer risk on BRCA1 carriers. [PDF]

Hered Cancer Clin Pract
Matuszczak M, Kiljańczyk A, Marciniak W, Derkacz R, Stempa K, Baszuk P, Bryśkiewicz M, Cybulski C, Dębniak T, Jacek G, Huzarski T, Lener M, Jakubowska A, Pietrzak S, Szwiec M, Stawicka-Niełacna M, Godlewski D, Prusaczyk A, Jasiewicz A, Kluz T, Tomiczek-Szwiec J, Kilar-Kobierzycka E, Siołek M, Posmyk R, Jarkiewicz-Tretyn J, Scott R, Narod S, Lubiński J.   +27 more
europepmc   +1 more source

Rusiecki Kanuty [PDF]

, 1992
Ostrowski, Jan K.
core  

Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis. [PDF]

Br J Cancer
Metcalfe K, Huzarski T, Gronwald J, Kotsopoulos J, Kim R, Moller P, Pal T, Aeilts A, Eisen A, Karlan B, Bordeleau L, Tung N, Olopade O, Zakalik D, Singer CF, Foulkes W, Couch F, Neuhausen SL, Eng C, Sun P, Lubinski J, Narod SA, Hereditary Breast Cancer Clinical Study Group.   +22 more
europepmc   +1 more source